Regeneron could be just a few months away from filing for approval of a therapy for the neuromuscular disorder generalised myasthenia gravis (gMG), cemdisiran, which can be dosed just four times a ...
29 For example, compared with lung cancer, patients with melanoma have a higher rate of change from severe to minor disability, as do patients with myositis or neuromuscular junction disorders. Older ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback